News

Tirzepatide and AOD-9604 for Alcohol Cravings: VA Trial Clues
A clinician I spoke with mentioned a curious pattern in early 2024. Patients on tirzepatide for weight loss were reporting less interest in alcohol. It was n... Read more...
Can AOD-9604 Be a Safer Alternative Amid FDA Warnings on Compounded GLP-1s?
As FDA warnings mount on compounded GLP-1s, researchers ask if AOD-9604 offers a safer path. This peptide fragment targets fat without appetite Read more...
Tirzepatide and MOTS-c Synergy for Metabolic Flexibility
Exploring the synergy between tirzepatide and MOTS-c for metabolic flexibility during weight loss, and what compounded access looks like after the FDA Read more...
AOD-9604 vs Tirzepatide for Lean Mass Preservation
AOD-9604 and tirzepatide are being stacked to preserve lean mass during GLP-1 weight loss, sparked by a MedPage study on muscle wasting Read more...
Tirzepatide vs Retatrutide for Stubborn Belly Fat
Tirzepatide and retatrutide both reduce weight, but retatrutide's triple-agonist activity may offer an edge for stubborn belly fat. Early data suggest greater Read more...
AOD-9604 and Compounded GLP-1s: Mitigating Muscle Loss
AOD-9604, a growth hormone fragment, is being explored as an adjunct to compounded tirzepatide to reduce muscle loss during rapid weight loss. This Read more...